Zika virus complete genome from Salvador, Bahia, Brazil. Infection, Genetics and Evolution, 41: 142-145 (2016).

Publication Latest Publications

Title: Zika virus complete genome from Salvador, Bahia, Brazil
Authors: surname=de OliveiraGiovanetti M, Faria NR, Nunes MR, de Vasconcelos JM, Lourenco J, Rodrigues SG, Vianez JL Jr, da Silva SP, Lemos PS, Tavares FN, Martin DP, do Rosario MS, Siqueira IC, Ciccozzi M, Pybus OG, de Oliveira T, Alcantara LC Junior.
Journal: Infection, Genetics and Evolution,41:142-145 (2016)

Journal Impact Factor (I.F.): 3.015
Number of citations (Google Scholar): 8

Abstract

In May 2015 the first autochthonous Zika virus infection was reported in Brazil. Rapid and urgent measures are needed to contain the ongoing outbreak. Here we report the full-length ZIKV coding sequence from Bahia. Genetic analysis of outbreak sequences will be essential for characterizing the diversity of circulating strains, identifying hotspots of virus transmission and guiding public health control. Rapid and urgent measures are needed to contain the ongoing outbreak.

Highlights:

- Phylogeny of Zika Virus was investigated by analyzing the complete genome sequence from Salvador Bahia, Brazil.

- Evolutionary analysis was investigated considering the Envelope, NS3, NS5 proteins of Zika Virus.

- This study reinforces the need to monitor the spread of the still ongoing outbreak of Zika Virus.

Download: Full text paper

Citation: surname=de OliveiraGiovanetti M, Faria NR, Nunes MR, de Vasconcelos JM, Lourenco J, Rodrigues SG, Vianez JL Jr, da Silva SP, Lemos PS, Tavares FN, Martin DP, do Rosario MS, Siqueira IC, Ciccozzi M, Pybus OG, de Oliveira T, Alcantara LC Junior. Zika virus complete genome from Salvador, Bahia, Brazil Infection, Genetics and Evolution,41:142-145 (2016).


Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration
Journal: EBioMedicine (2017)

High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients
Journal: Clinical Infectious Diseases (2017)

Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
Journal: Clinical Infectious Diseases (2017)
All publications...


Page design updated by Tulio de Oliveira, 2013